• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Center for Cancer and Blood Disorders Joins AON

Article

American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON.

Fort Myers, Fla., May 4, 2020—American Oncology Network, LLC (AON) is pleased to announce that The Center for Cancer and Blood Disorders (CCBD), a leading community oncology and hematology practice serving Bethesda and Germantown, Maryland, has joined AON, effective May 1, 2020. The Center for Cancer and Blood Disorders team includes three medical oncologists providing the highest quality of care, with state-of-the-art technology, and the latest advances in clinical research and therapies. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. The partnership with AON will help expand patient services such as home delivery of oral oncolytic medications, patient education, and 24/7 pharmacy assistance.

AON CEO Brad Prechtl, MBA stated, “We are excited for Drs. Boccia, Priego and Goldstein and the entire Center for Cancer and Blood Disorders team to join our growing network of community oncologists helping to bring the very best in cancer care and treatment to patients, close to where they live.”

“The Center for Cancer and Blood Disorders will remain focused on integrating the best medicine in an environment that helps patients overcome obstacles such as easier access to medications and financial counseling,” said AON Board Member & Chairman Dr. Stephen Orman.

Read the full press release here.

Related Videos
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.